Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The iLet Experience Study

NCT: NCT06891898 · RECRUITING

NCT IDNCT06891898
StatusRECRUITING
Start Date2024-05-01
Completion2027-06
SponsorBeta Bionics, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

A one-year, prospective single-arm cohort study to collect safety and effectiveness data on the iLet Dosing Decision Software during real-world use in people 6 years of age or older with type 1 diabetes (T1D) with 12 months follow-up.

Frequently Asked Questions

What is The iLet Experience Study?

The iLet Experience Study is a clinical trial registered under NCT06891898. Current status: RECRUITING.

What is the status of NCT06891898?

The current status of NCT06891898 (The iLet Experience Study) is: RECRUITING.

When did The iLet Experience Study start?

The iLet Experience Study started on 2024-05-01.

Related Devices

K220916iLet® Dosing Decision SoftwareBeta Bionics, Inc. K232224iLet® Dosing Decision SoftwareBeta Bionics, Inc. K223846iLet® ACE PumpBeta Bionics, Inc. K231485iLet® ACE PumpBeta Bionics, Inc. K252770iLet ACE PumpBeta Bionics, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑